Detection and Monitoring of Circulating Tumor Cells (CTC's)
Type of CANCER
All Types of Cancer
Except for the Cabeca and Central Nervous System
RESULT Time
10 to 14 working days
What is the RGCC Oncotrace?
It is the Follow-up Profile of Circulating Tumor (CTC's) in which:
Determines the Presence and Concentration of Circulating Tumor Cells (CTC's)
Evaluation of Markers of both Circulating and Stem Cell Cancer (responsible for initiation of the primary tumor and metastization).
Immunophenotyping (method for characterization of the primary tumor when unknown).
Early Detection?
The Oncotrace Profile also acts on Early Detection of Cancer as a preventive measure for patients wishing to screen for Highly Sensitive Biomarkers of Tumor Cells.
